Key result
Prevention and treatment of atrial fibrillation in patients with cardiovascular disease can significantly reduce mortality, stroke incidence, and medical costs.
Why the study?
Does prevention and treatment of AF reduce mortality, stroke, and medical costs in patients with AF and associated CVD?
Does prevention and treatment of AF reduce mortality, stroke, and medical costs in patients with AF and associated CVD?
Prevention and treatment of atrial fibrillation and associated cardiovascular disease may reduce mortality, stroke, and health care costs.
May support integrated AF care in CVD to curb events and costs; extends observational data but leaves causality for RCTs.
Prevention of AF and treatment of patients with AF and associated CVD may yield benefits in reduced mortality and stroke as well as reducing health care costs.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (1998) studied this question. Prevention and treatment of atrial fibrillation in patients with cardiovascular disease can significantly reduce mortality, stroke incidence, and medical costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: